• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描/计算机断层扫描(PET/CT)氟代脱氧葡萄糖代谢肿瘤体积可预测原发性脊柱/脊髓恶性肿瘤的临床转归。

Metabolic Tumor Volume by F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors.

机构信息

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Japan.

出版信息

Biomed Res Int. 2017;2017:8132676. doi: 10.1155/2017/8132676. Epub 2017 Aug 9.

DOI:10.1155/2017/8132676
PMID:28852650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5568596/
Abstract

BACKGROUND AND PURPOSE

Primary malignant spine/spinal tumors (PMSTs) are rare and life-threatening diseases. In this study, we demonstrated the advantage of volume-based F-FDG PET/CT metabolic parameter, metabolic tumor volume (MTV), for assessing the aggressiveness of PMSTs.

MATERIALS AND METHODS

We retrospectively reviewed 27 patients with PMSTs and calculated SUV, MTV, and total lesion glycolysis (TLG) to compare their accuracy in predicting progression-free survival (PFS) and overall survival (OS) by receiver operating characteristic (ROC) curve analysis. Univariate and multivariate analyses were used to compare the reliability of the metabolic parameters and various clinical factors.

RESULTS

MTV exhibited greater accuracy than SUV or TLG. The cut-off values for PFS and OS derived from the AUC data were MTV 45 ml and 83 ml and TLG 250 SUV⁎ml and 257 SUV⁎ml, respectively. MTV above cut-off value, but not TLG, was identified as significant prognostic factor for PFS by log-lank test ( = 0.04). In addition, MTV was the only significant predictive factors for PFS and OS in the multivariate analysis.

CONCLUSIONS

MTV was a more accurate predictor of PFS and OS in PMSTs compared to TLG or SUV and helped decision-making for guiding rational treatment options.

摘要

背景与目的

原发性脊柱/脊髓恶性肿瘤(PMST)是一种罕见且危及生命的疾病。在本研究中,我们展示了基于体积的 F-FDG PET/CT 代谢参数代谢肿瘤体积(MTV)在评估 PMST 侵袭性方面的优势。

材料与方法

我们回顾性分析了 27 例 PMST 患者,并计算了 SUV、MTV 和总病变糖酵解(TLG),通过受试者工作特征(ROC)曲线分析比较其预测无进展生存期(PFS)和总生存期(OS)的准确性。采用单因素和多因素分析比较代谢参数和各种临床因素的可靠性。

结果

MTV 的准确性优于 SUV 或 TLG。AUC 数据得出的 PFS 和 OS 的截断值分别为 MTV45ml 和 83ml,TLG250SUV⁎ml 和 257SUV⁎ml。对数秩检验( = 0.04)表明,MTV 高于截断值而非 TLG 是 PFS 的显著预后因素。此外,MTV 是多因素分析中 PFS 和 OS 的唯一显著预测因素。

结论

与 TLG 或 SUV 相比,MTV 是 PMST 患者 PFS 和 OS 的更准确预测指标,有助于指导合理治疗方案的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/ab8f5679e360/BMRI2017-8132676.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/b1f7661d095d/BMRI2017-8132676.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/2ebe418539a1/BMRI2017-8132676.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/890b747ad61e/BMRI2017-8132676.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/9c04b2cd135c/BMRI2017-8132676.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/ab8f5679e360/BMRI2017-8132676.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/b1f7661d095d/BMRI2017-8132676.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/2ebe418539a1/BMRI2017-8132676.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/890b747ad61e/BMRI2017-8132676.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/9c04b2cd135c/BMRI2017-8132676.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f977/5568596/ab8f5679e360/BMRI2017-8132676.005.jpg

相似文献

1
Metabolic Tumor Volume by F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors.正电子发射断层扫描/计算机断层扫描(PET/CT)氟代脱氧葡萄糖代谢肿瘤体积可预测原发性脊柱/脊髓恶性肿瘤的临床转归。
Biomed Res Int. 2017;2017:8132676. doi: 10.1155/2017/8132676. Epub 2017 Aug 9.
2
[Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].[预处理(18)F-FDG PET-CT对晚期弥漫性大B细胞淋巴瘤患者的预后价值]
Zhonghua Zhong Liu Za Zhi. 2018 Jul 23;40(7):528-533. doi: 10.3760/cma.j.issn.0253-3766.2018.07.009.
3
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.预处理 18F-FDG PET/CT 测量的容积参数对皮肤恶性黑色素瘤患者的预后价值。
Clin Nucl Med. 2016 Jun;41(6):e266-73. doi: 10.1097/RLU.0000000000001205.
4
Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.18F-FDG PET/CT 总病灶糖酵解是软组织肉瘤预后的可靠预测指标。
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1836-42. doi: 10.1007/s00259-013-2511-y. Epub 2013 Jul 24.
5
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.预处理代谢肿瘤体积和 18F-FDG PET/CT 总病变糖酵解对接受抗血管内皮生长因子靶向药物治疗的转移性肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 May;42(5):e235-e241. doi: 10.1097/RLU.0000000000001612.
6
[Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].[治疗前(18)F-FDG PET-CT代谢参数在晚期结外NK/T细胞淋巴瘤患者中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2019 Nov 23;41(11):831-836. doi: 10.3760/cma.j.issn.0253-3766.2019.11.006.
7
Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with F-FDG PET/CT, in patients with diffuse large cell B-cell lymphoma.评估 F-FDG PET/CT 计算肿瘤代谢体积的不同方法对弥漫性大 B 细胞淋巴瘤患者的预后价值。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):340-346. doi: 10.1016/j.remn.2020.06.007. Epub 2020 Jul 6.
8
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.局部晚期非小细胞肺癌患者风险分层的 FDG PET/CT 最佳容积学参数:来自 ACRIN 6668/RTOG 0235 试验的结果。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8.
9
Comparison of the prognostic values of F-fluorodeoxyglucose parameters from colon and non-colon sites of involvement in diffuse large B-cell lymphoma of the colon.比较累及结肠和非结肠部位的弥漫性大 B 细胞淋巴瘤的 F-氟代脱氧葡萄糖参数的预后价值。
Sci Rep. 2020 Jul 29;10(1):12748. doi: 10.1038/s41598-020-69550-6.
10
Texture analysis of F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.利用F-FDG PET/CT进行纹理分析以预测接受放化疗的食管癌患者的肿瘤反应和预后。
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):206-214. doi: 10.1007/s00259-016-3506-2. Epub 2016 Sep 10.

引用本文的文献

1
A Systematic Review of the Applications of Deep Learning for the Interpretation of Positron Emission Tomography Images of Patients with Lymphoma.深度学习在淋巴瘤患者正电子发射断层扫描图像解读中的应用系统评价
Cancers (Basel). 2024 Dec 29;17(1):69. doi: 10.3390/cancers17010069.
2
The role of baseline F-FDG PET/CT for survival prognosis in NSCLC patients undergoing immunotherapy: a systematic review and meta-analysis.基线F-FDG PET/CT在接受免疫治疗的非小细胞肺癌患者生存预后中的作用:一项系统评价和荟萃分析
Ther Adv Med Oncol. 2024 Nov 4;16:17588359241293364. doi: 10.1177/17588359241293364. eCollection 2024.
3

本文引用的文献

1
Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.基于体积的F-18氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像标记物为高级别骨肉瘤或软组织肉瘤患者的组织学分级提供补充预后信息。
Medicine (Baltimore). 2015 Dec;94(51):e2319. doi: 10.1097/MD.0000000000002319.
2
Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass.新型子宫肉瘤术前诊断评分可预测子宫肿物患者的手术需求。
Springerplus. 2014 Nov 18;3:678. doi: 10.1186/2193-1801-3-678. eCollection 2014.
3
A Rare Case of Melanotic Schwannoma Occurred Intraosseous of Sacrum: A Literature Review.
罕见的骶骨骨内黑色素性雪旺细胞瘤病例:文献复习。
Orthop Surg. 2023 Feb;15(2):655-662. doi: 10.1111/os.13606. Epub 2022 Dec 1.
4
Tumor Size Measurements for Predicting Hodgkin's and Non-Hodgkin's Lymphoma Response to Treatment.用于预测霍奇金淋巴瘤和非霍奇金淋巴瘤治疗反应的肿瘤大小测量
Metabolites. 2022 Mar 24;12(4):285. doi: 10.3390/metabo12040285.
5
Assessing the Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis Between Spinal Schwannomas and Meningiomas.评估18F-氟脱氧葡萄糖正电子发射断层扫描在脊髓神经鞘瘤和脑膜瘤鉴别诊断中的效用。
Cureus. 2021 Oct 19;13(10):e18890. doi: 10.7759/cureus.18890. eCollection 2021 Oct.
6
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC.甲状腺乳头状癌伴微小癌中放射性碘难治性疾病及总生存期短的预测因素
Cancers (Basel). 2021 Apr 6;13(7):1728. doi: 10.3390/cancers13071728.
7
Intraosseous Melanotic Schwannoma in the Sacrum Mimicking Primary Bone Tumor.骶骨内黑色素性神经鞘瘤酷似原发性骨肿瘤
NMC Case Rep J. 2020 Jun 26;7(3):107-111. doi: 10.2176/nmccrj.cr.2019-0238. eCollection 2020 Jul.
8
PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review.PET-CT评估克唑替尼对ALK R401罕见突变的恶性肌成纤维细胞瘤的疗效:一例报告及文献复习
Onco Targets Ther. 2018 Apr 5;11:1921-1927. doi: 10.2147/OTT.S155033. eCollection 2018.
Malignant peripheral nerve sheath tumors presenting as spinal dumbbell tumors: clinical outcomes and characteristic imaging features.
表现为脊髓哑铃形肿瘤的恶性周围神经鞘瘤:临床结果及特征性影像学表现
Eur Spine J. 2015 Oct;24(10):2119-25. doi: 10.1007/s00586-014-3467-8.
4
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.术前 ¹⁸F-FDG PET/CT 代谢肿瘤体积和总病变糖酵解对胰腺癌患者的预后价值。
J Nucl Med. 2014 Jun;55(6):898-904. doi: 10.2967/jnumed.113.131847. Epub 2014 Apr 7.
5
Primary Spinal Tumor Mortality Score (PSTMS): a novel scoring system for predicting poor survival.原发性脊柱肿瘤死亡率评分(PSTMS):一种用于预测不良生存情况的新型评分系统。
Spine J. 2014 Nov 1;14(11):2691-700. doi: 10.1016/j.spinee.2014.03.009. Epub 2014 Mar 17.
6
Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.18F-FDG PET/CT在软组织肉瘤患者中的预后价值:代谢参数之间的比较
Skeletal Radiol. 2014 May;43(5):641-8. doi: 10.1007/s00256-014-1832-7. Epub 2014 Feb 15.
7
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.肉瘤治疗中期 [F-18]氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)与患者预后。
J Bone Joint Surg Am. 2014 Jan 15;96(2):152-8. doi: 10.2106/JBJS.M.00062.
8
Initial metabolic tumor volume measured by 18F-FDG PET/CT can predict the outcome of osteosarcoma of the extremities.18F-FDG PET/CT 测量的初始代谢肿瘤体积可预测四肢骨肉瘤的预后。
J Nucl Med. 2013 Oct;54(10):1725-32. doi: 10.2967/jnumed.112.117697. Epub 2013 Aug 15.
9
Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.18F-FDG PET/CT 总病灶糖酵解是软组织肉瘤预后的可靠预测指标。
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1836-42. doi: 10.1007/s00259-013-2511-y. Epub 2013 Jul 24.
10
Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.18F-FDG PET/CT 代谢活性与骨和软组织肉瘤组织病理学特征的相关性:136 例患者的回顾性研究。
AJR Am J Roentgenol. 2012 Jun;198(6):1409-16. doi: 10.2214/AJR.11.7560.